These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9001077)
1. The FDA warns of the dangers of ephedrine. Chase SL RN; 1996 Dec; 59(12):67. PubMed ID: 9001077 [No Abstract] [Full Text] [Related]
2. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients. Lipman AG J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627 [No Abstract] [Full Text] [Related]
3. Ephedrine's deadly edge. Turk MP US News World Rep; 1997 Jul; 123(1):79-80. PubMed ID: 10168348 [No Abstract] [Full Text] [Related]
4. Reconsidering the safety of over-the-counter decongestants. Caravati EM Ann Emerg Med; 2005 Feb; 45(2):217-8. PubMed ID: 15671980 [No Abstract] [Full Text] [Related]
5. Cardiomyopathy due to ingestion of Adderall. Marks DH Am J Ther; 2008; 15(3):287-9. PubMed ID: 18496266 [TBL] [Abstract][Full Text] [Related]
6. Bad news for dieters: a focus on ephedrine. Riffel K Kans Nurse; 2003 Apr; 78(4):6-9. PubMed ID: 12769034 [No Abstract] [Full Text] [Related]
8. [Ephedrine and ephedra in weight loss products and other preparations]. van der Hooft CS; Stricker BH Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223 [TBL] [Abstract][Full Text] [Related]
9. Ephedrine alkaloids banned from dietary supplements. Thompson CA Am J Health Syst Pharm; 2004 Apr; 61(8):750-2, 756. PubMed ID: 15127956 [No Abstract] [Full Text] [Related]
10. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids. Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868 [TBL] [Abstract][Full Text] [Related]
11. Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine. Spiller HA; Griffith JR; Anderson DL; Weber JA; Aleguas A Ann Pharmacother; 2008 Jul; 42(7):1142-3. PubMed ID: 18594051 [No Abstract] [Full Text] [Related]
13. Theophylline is off the OTC market. Ephedrine may be next. Chase SL RN; 1995 Dec; 58(12):79. PubMed ID: 8560184 [No Abstract] [Full Text] [Related]
14. Banning ephedra: good call, poor vision. Gordon JS Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346 [No Abstract] [Full Text] [Related]
15. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596 [TBL] [Abstract][Full Text] [Related]
17. Second FDA panel advises on stimulants. Child Health Alert; 2006 May; 24():4. PubMed ID: 16718925 [No Abstract] [Full Text] [Related]
18. Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994? Lindsay BD Mayo Clin Proc; 2002 Jan; 77(1):7-9. PubMed ID: 11795250 [No Abstract] [Full Text] [Related]
19. Over-the-counter-drugs: epidemiology, adverse reactions, overdose deaths, and mass media promotion. Inciardi JA Addict Dis; 1977; 3(2):253-72. PubMed ID: 28642 [No Abstract] [Full Text] [Related]
20. ADHD drugs and cardiovascular risk. Rappley MD; Moore JW; Dokken D N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375 [No Abstract] [Full Text] [Related] [Next] [New Search]